Trk inhibitor attenuates the BDNF/TrkB-induced protection of neuroblastoma cells from etoposidein vitroandin vivo

Brain-Derived Neurotrophic Factor Promotes Vasculature-Associated Migration of Neuronal Precursors toward the Ischemic Striatum

(2013) Sofia Grade et al.   PLoS One

AZ64 inhibits TrkB and enhances the efficacy of chemotherapy and local radiation in neuroblastoma xenografts

(2012) Radhika Iyer et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Perifosine-induced inhibition of akt attenuates brain-derived neurotrophic factor/TrkB-induced chemoresistance in neuroblastoma in vivo

(2011) Zhijie Li et al.   CANCER

Preclinical evaluation of lestaurtinib (CEP-701) in combination with retinoids for neuroblastoma

(2011) Robin E. Norris et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

The selective Trk inhibitor AZ623 inhibits brain-derived neurotrophic factor-mediated neuroblastoma cell proliferation and signaling and is synergistic with topotecan

(2010) Peter E. Zage et al.   CANCER

Lestaurtinib, a multitargeted tyrosinse kinase inhibitor: from bench to bedside

(2010) Munira Shabbir et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS